2024-11-20 03:31:51
I-Mab to Present Phase 2 Clinical Data of CD47 Antibody Lemzoparlimab at ESMO Congress 2022
Corporate/ 2023-07-24
I-Mab to Present Phase 2 Clinical Data o...

GAITHERSBURG,Md. and SHANGHAI,July 18,2022-- I-Mab (the "Company") (Nasdaq: IMAB),a clinical-stage biopharmaceutical company commi...

Samsung Biologics to purchase land for its second Bio Campus
Corporate/ 2023-07-24
Samsung Biologics to purchase land for i...

Acquires additional land,sized 357,366㎡ valued at KRW 426 billion,for Bio Campus 2 Plans to build Multi-Modal Plant,Open Innovation,and exp...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release